PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Primary Immune Deficiencies Unit, Azienda Ospedaliera Universitaria Policlinico Umberto I, Rome, Italy.\', \'Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.\', \'Department of Medicine-DIMED, University of Padova, and Internal Medicine I, Ca\' Foncello Hospital, AULSS2 Marca Trevigiana, Treviso, Italy.\', \'Department of Molecular Medicine, Sapienza University of Rome and Diagnostic Immunology Research Unit, Multimodal Medicine Research Area, Bambino Gesù Children\'s Hospital, IRCCS, Rome, Italy.\', \'Diagnostic Immunology Research Unit, Multimodal Medicine Research Area, Bambino Gesù Children\'s Hospital, IRCCS, Rome, Italy.\', \'Department of Public Health and Infectious Diseases, Sapienza University of Rome, Italy.\', \'Infectious Diseases Unit, SM Goretti Hospital, Sapienza University of Rome, Latina, Italy.\', \'National Institute for Infectious Diseases \'Lazzaro Spallanzani\' IRCCS, Rome, Italy.\', \'POIT-INMI Spallanzani Infectious Diseases/Hepatology Unit, Rome, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1093/infdis/jiab554
?:hasPublicationType
?:journal
  • The Journal of infectious diseases
is ?:pmid of
?:pmid
?:pmid
  • 34746954
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Combination Therapy in Patients With Coronavirus Disease 2019 and Primary Antibody Deficiency.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all